A Review on Antibiotic Resistant and Implication on Food Chain by Addis, Mekonnen
Food Science and Quality Management                                                                                                                                             www.iiste.org 
ISSN 2224-6088 (Paper)  ISSN 2225-0557 (Online) 
Vol.42, 2015 
 
29 
A Review on Antibiotic Resistant and Implication on Food Chain 
 
Mekonnen Addis 
School of Veterinary Medicine, College of Agriculture and Veterinary Medicine, Jimma University, P.O. Box: 
307, Jimma, Ethiopia.  
 
SUMMARY 
Antibiotic are important tools that are integral to our complex food system and provide for high quality or good 
physical condition of food animals entering the food chain. Antibiotic resistance may be intrinsic to a 
microorganism, or it may develop via mutation or adaptation to stressors. Antibiotic-resistant pathogens may 
create an increased burden to human health in different ways: (1) resistant pathogens contaminating food animals 
have the potential to reach humans; (2) human use of antibiotics may increase the risk of acquiring an infection 
with an antimicrobial resistant pathogen; (3) human infection with a resistant microbe may limit illness treatment 
options (in the uncommon instances of food borne illness in which antibiotic use is warranted); and (4) 
antibiotic-resistant food borne pathogens may develop increased virulence. The extent to which antibiotic use in 
food animals produces clinically important antibiotic-resistant infections in humans is unknown. Antibiotic-
resistant intestinal bacteria may be present in food animals, regardless of exposure of the animals to an antibiotic. 
In spite of the best efforts to prevent or eliminate them, some antibiotic-resistant bacteria contaminate carcasses, 
as do antibiotic susceptible bacteria. The key points of influence that food scientists have in preventing the 
spread of antibiotic-resistant and sensitive pathogenic microorganisms in foods are preventing them from 
entering the food supply, and if present, inactivating them or preventing their growth. Interventions that 
effectively reduce the prevalence of foodborne pathogens also reduce the prevalence of those that are resistant to 
antibiotics. Risk management strategies to minimize and contain antibiotic resistant foodborne bacteria are in 
place all along the food chain, but can be improved. The strategies that have been implemented include use of 
antibiotic alternatives, implementation of judicious or prudent antibiotic use guidelines, and implementation of 
national resistance monitoring programs. 
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INTRODUCTION 
Antibiotics are widely used in human and veterinary medicine, and have been essential for ensuring human and 
animal health. However, the emergence of bacteria resistant to commonly used antibiotics compromises effective 
treatment, resulting in the need for stronger drugs and more costly therapy. The spectre of antibiotic-resistant 
(ART) microbes is a worldwide concern due to the public perception of an incoming post-antibiotic era. Besides 
clinical therapy, antibiotics have also been used to improve aquaculture and agriculture production (Wang et al., 
2012). 
Certain antibiotics used for treatment or growth promotion in agriculture are also used for disease 
control in humans. Others select for cross-resistance in bacteria to antibiotics used in human medicine. 
Microbiological and clinical evidence is mounting that resistant bacteria or resistance determinants might be 
passed from animals to humans, resulting in infections that are more difficult to treat. With an increase in the 
prevalence and distribution of antibiotic-resistant infections in hospitals and the community, the question has 
been raised as to how this escalation of resistance could have been influenced by the use of antibiotics in 
livestock production (WHO, 1997). 
Antibiotic resistant infections occur too often and with increasing frequency, interfering with the 
effective treatment of people and animals. Although antibiotics and antibiotic resistance are natural phenomena, 
the population of resistant bacteria has increased by the introduction of antibiotics into an environment. To 
preserve the effectiveness of antibiotics, it is critical to examine the uses of these drugs, in both humans and 
animals. This series of talking points developed for use by dietetic and nutrition professionals will provide a 
background on the use of subtherapeutic antibiotics in animals (CDC, 2008). 
None the less, evidence is mounting that antibiotic-resistant enteric bacteria (for example, Escherichia 
coli, salmonella, campylobacter and enterococci) can transfer from animals to man via the food chain or by 
direct contact, leading to the establishment of a community reservoir of resistance genes (van den Bogaard and 
Stobberingh, 1999). Therefore, protection of food supplies includes microbiological quality and safety of 
commodities available for public consumption. While such concerns most frequently address pathogenic 
microorganisms, that present immediate risks to human health, there is growing interest in commensal 
components of the microbiota associated with food (Hayes et al., 2003) 
The use of antibiotics in food animals and the emergence of resistant bacteria in the food chain have 
been the subject of numerous national and international consultations. The issues relating to antibiotic resistant 
bacteria in live animals are discussed internationally by veterinary, microbiological and epidemiological 
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expertise through the OIE (Office International des Epizooties), FAO (Food and Agriculture Organisation), 
VICH (Veterinary International Cooperation on Harmonisation) and the CCRVDF (Codex Committee for 
Residues of Veterinary Drugs in Foods) (FAO and WHO,1999). 
In spite of the aforementioned prevailing situation and the presence of a number of public health 
problems due to antibiotic resistant pathogens resulting from the consumption of different food items in 
Ethiopia, there is paucity of well-documented review on antibiotic resistance and implication on food chain. 
Therefore, this review was designed to: 
♦ Review and give background information on antibiotic resistance and implication on food chain  
♦ Recommend control measures and further study on antibiotic resistance and implication on food chain  
 
ANTIBIOTIC RESISTANCE 
Antibiotic resistance is the ability of a bacterium or other microorganism to survive and reproduce in the 
presence of antibiotic doses that were previously thought effective against them (WHO, 2011). Resistance is 
often associated with reduced bacterial fitness, and it has been proposed that a reduction in antibiotic use (and, 
therefore, in the selective pressure to acquire resistance) would benefit the fitter susceptible bacteria, enabling 
them to outcompete resistant strains over time (Levin, 2007). 
 
Origin of Antibiotic Resistance 
Most cells in a naive, susceptible bacterial population causing an infection are susceptible to the antibiotic of 
choice for treatment, and are killed upon exposure to it; however there is always a minute sub-population of 
resistant cells that will be able to multiply at higher concentrations (Smith and Crabb, 2008).  
If the antibiotic concentration is not sufficiently high to kill this subpopulation then the environment is 
such that this population is selected. The accepted dogma is that these resistant cells arise by random mutations 
in bacteria and that occasionally these random mutations occur in a gene that affects antibiotic susceptibility. 
This gene is then stably inherited by all daughter progeny if, as is usual, the gene is chromosomal. Sometimes 
the gene is on an extra chromosomal element alternatively, the bacterium acquires a resistance gene(s) from 
another bacterium. Evidence for the existence of resistance genes prior to exposure to antibiotics comes from 
examination of historic cultures from before the antibiotic era (Smith, 2002), from the examination of bacteria 
from populations in the process of exposure to antibiotic (Smith and Crabb, 2008) and by examining populations 
of bacteria in locations remote from any antibiotic use such as farm animal species in isolation, wildlife and soil 
bacteria (Mare, 1998).  
 
Figure 1: Relationship between antibiotic use and development of resistance. 
Antibiotic use is the main factor in the forward process, i.e. selection of resistance, but other factors can 
influence that relationship. Factors dependent on humans, and their management of antibiotics, are represented 
above the horizontal arrow, while factors related to the antibiotic itself and the genetic basis of resistance are 
represented below the horizontal arrow. 
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Classification of Antibiotic Resistance 
Resistance to most traditional, regulatory-approved, or naturally-occurring food antibiotic agents is difficult to 
characterize because of the lack of a precise definition for such resistance. From a functional perspective, 
resistance correlates with failure of a given antibiotic treatment; whereas from a laboratory perspective, 
resistance is denoted through a “Minimal Inhibitory Concentration” (MIC) value that exceeds a threshold value, 
which may or may not be associated with a clinical outcome. A microorganism is resistant if it exhibits 
“significantly reduced susceptibility” when compared with that of the “original isolate” or a group of sensitive 
strains (Chapman, 1998). Resistance can result from mutations in housekeeping structural or regulatory genes, or 
alternatively, horizontal acquisition of foreign genetic information (Courvalin, 2005). 
 
Figure 2: Horizontal gene transfer: resistance gene being transferred from one bacterium to another 
 
Innate resistance 
As is the case for a natural property of a microorganism, innate (intrinsic) resistance is chromosomally controlled 
(Russell, 1991). Innate resistance is related to the general physiology or anatomy of a microorganism and stems 
from pre-existing mechanisms or properties. This type of resistance is most likely responsible for differences in 
resistance observed among different types, genera, species, and strains of microorganisms in identical 
environmental conditions and concentrations (Gilbert and McBain, 2003).  
Innate resistance may stem from the complexity of the cell wall, efflux mechanisms (means by which 
microbes pump antibiotics out of the cell or enzymatic inactivation of the antibiotic (Russell, 2001). Innate 
resistance is not considered an important clinical problem because antibiotics were never intended for use against 
intrinsically resistant bacteria. There are certain circumstances in which antibiotics do not adversely affect 
bacteria that are generally susceptible to the particular agent. Because the efficacy of most food antibiotics and 
sanitizers is dependent upon and influenced by the conditions of the application, some situations may permit 
bacterial resistance that would not have occurred otherwise (IFT, 2002a).  
 
Acquired resistance 
Acquired (extrinsic) resistance results from genetic changes that occur through mutation of the antibiotic’s target 
site within the bacterium or acquisition of genetic material encoding resistance via plasmids or transposons 
containing integron sequences. Acquired resistance, the most common type of antibiotic resistance, has been 
well studied for antibiotics, but has not been well studied for food antimicrobial agents and sanitizers (Russell, 
1991). 
Acquisition of genes for β-lactamase (an enzyme capable of breaking down and inactivating β-lactam 
antibiotics [penicillins and cephalosporins]) and mutation of one of the subunits of DNA gyrase (the target of 
fluoroquinolones) are examples of this type of resistance. Another example includes resistance of some 
microorganisms to sanitizing compounds, such as quaternary ammonium compounds (QACs), as a result of the 
presence of plasmid-encoded efflux pumps that remove the QACs (Gilbert and McBain, 2003).  
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Adaptation 
For certain types of antibiotics, adaptation, may be demonstrated by exposing a microorganism to a stepwise 
increase in concentration of the substance. This type of resistance, however, is often unstable; the microorganism 
may revert back to the sensitive phenotype when grown in an antibiotic-free medium, termed “back-mutation” 
(Russell, 1991). 
 
Antibiotic Resistance in Animals 
Most concern about antibiotic resistance in animal isolates of bacteria is directed towards the enteric bacteria, E. 
coli, salmonella, thermophilic campylobacters and enterococci (Smith, 2005). Resistance to other antibiotics was 
detected as new agents were introduced for therapeutic and growth-promoting purposes (Anderson, 2000). 
Feeding oxytetracycline to recently-weaned pigs was found to lead to a rapid increase in the incidence 
of tetracycline resistance, which was widely distributed among all strains of E. coli present, rather than being 
restricted to a few selected clones (Hinton et al., 2004). More recently, feeding low doses of ampicillin to 
chickens was shown to select for high levels of resistance to that antibiotic (El-Sam et al., 1993). In herds and 
flocks treated with tetracycline, aminoglycoside and sulphonamide, widespread resistance is seen (Sunde et al., 
1998). Resistance is generally less prevalent in salmonella, but that resistance to tetracyclines, sulphonamides 
and streptomycin is quite widespread (Griggs et al., 1994). 
 
ANTIBIOTIC RESISTANCE IN RELATION TO FOOD SAFETY 
Antibiotic Use in Food Production 
In food animals, antibiotics are predominantly used to treat respiratory and enteric infections in groups of 
intensively fed animals. They are used especially during the early part of an animal’s life – for example, in 
broiler chickens and in weaning pigs and calves. Antibiotics are also used to treat infections in individual 
animals caused by a variety of bacterial pathogens. In particular, antibiotics are often used to treat mastitis in 
dairy cows, common infections in cows with a high milk output (Smith, 2005). 
Further, the global increase in intensive fish farming has been accompanied by bacterial infections that 
are usually treated with antibiotics added to fish foodstuffs. Similar to other industrialized food-animal 
production, the usage of antibiotics in aquaculture can be substantial. They may also be used for long periods at 
low levels to promote growth, increase feed efficiency, or compensate for unsanitary growing conditions on 
concentrated animal feeding operations (WHO, 2011).  
 
Antibiotic Resistance as a Food Safety Problem 
Food products of animal origin are often contaminated with bacteria, and thus likely to constitute the main route 
of transmitting resistant bacteria and resistance genes from food animals to people. Direct contact with animals 
or the animal environment, however, may also be of significance, depending on the type of bacteria. Such foods 
as fruits and vegetables contaminated by animal waste or contaminated water may also constitute a transmission 
route (WHO, 2011).  
There is clear evidence of adverse human health consequences due to resistant organisms resulting from 
nonhuman usage of antibiotics. These consequences include infections that would not have otherwise occurred, 
increased frequency of treatment failures (in some cases death) and increased severity of infections, as 
documented for instance by fluoroquinolone resistant human Salmonella infections (WHO, 2003). 
 
TRANSMISSION OF ANTIBIOTIC RESISTANT BACTERIA TO HUMAN 
Antibiotic resistance bacteria spread from animal to human indirectly via food (e.g. by contamination of carcases 
during slaughter), or less commonly by direct contact (e.g. in farmers, abattoir workers) (JETACAR, 1999). 
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Figure 3: Transmission of Antibiotic Resistant Strain of Bacteria from Animal to Man 
 
Major Food Vehicle of Antibiotic Resistant Bacteria 
The presence of antibiotic resistant bacteria in foodstuffs of animal origin is becoming a matter of concern as 
these bacteria can be transmitted to humans through food supply. Therefore, protection of food supplies includes 
microbiological quality and safety of commodities available for public consumption. While such concerns most 
frequently address pathogenic microorganisms, that present immediate risks to human health, there is growing 
interest in commensal components of the microbiota associated with food (Hayes et al., 2003; Martin et al., 
2005). 
Researchers have suggested that enterococci can transfer antibiotic resistance genes through food. It has 
been shown that the same antibiotic resistance genes were found in bacteria isolated from unpasteurized cheese 
and in bacteria isolated from human patients (Ogier et al., 2008). Moreover, most of the human clinical 
Enterococcus spp. isolates are species that normally colonize humans (Shaked et al., 2006). 
 
Dairy products 
Direct transfer of antibiotics resistant microorganisms to human through consumption of milk is unlikely 
because most milk is pasteurised (Teuber and Perreten, 2000). The relationship between antibiotic residues in 
milk and the development or transfer of resistant pathogens appears to be hypothetical (Tikofsky et al., 2003).  
Milk can be contaminated with feed pathogens that glycerol to from an organic boric acid and the 
alkalinity exhibit resistance to antibiotic and raw milk products have been implicated as mechanisms for 
transferring antibiotic resistant organism from farm environments to humans (Kalman et al., 2000). Safe milk 
should not contain residues of antibiotic (Said et al., 2008). These residues are a result of treating dairy cattle 
with antibiotic and not with holding milk (Norman et al., 2000). Antibiotic residues may also impact the 
manufacturing process of milk products (Booth et al., 1998). 
Antibiotic residues occur in milk supplies throughout the world, in some relatively unregulated markets, 
antibiotic residues may exist in 8-15% of total bulk tank loads (Shitandi et al., 2004). Purpose of antibiotic 
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sensitivity testing is to determine the susceptibility of bacteria to various antibiotics. This standardized test is 
used to measure the effectiveness of a variety of antibiotics on a specific organism in order to prescribe the most 
suitable antibiotic therapy (Madigan et al., 2000). 
 
Meat products  
Antibiotic-resistant Salmonella, Campylobacter, E. coli and multidrug-resistant Staphylococcus have been 
detected in many different types of retail meat and poultry products, as well as in farm animals and the farm 
environment (Bhargava et al., 2011). The presence of Enterococcus spp. in the gastrointestinal tract of animals 
may lead to contamination of meat at the time of slaughtering. Besides raw meats, they are also associated with 
processed meats (Franz et al., 1999). 
Heating of processed meats during production may confer a selective advantage to enterococci because 
these bacteria are among the most thermotolerant of the non-sporulating bacteria. After surviving the heat-
processing step, enterococci have been implicated in spoilage of cured meat products, such as canned hams and 
chub packed luncheon meats (Magnus et al., 2008). This is especially true where recontamination with 
competing bacteria is prevented, when products are heated after packaging in cans or in impermeable plastic 
films. The heat resistance of Enterococcus spp. in these products is influenced by components such as salt, 
nitrite, and meat tissue (Franz et al., 1999). 
 
Sea foods 
Antibiotic-resistant pathogens have also been obtained from seafood products. For example, the trimethoprim-
sulfamethoxazole (SXT) resistance of fish pathogen aeromonads isolated from seafood products in Germany 
(Kadlec et al., 2011).  Antibiotic resistance was also detected in Vibrio parahaemolyticus isolated from shellfish 
from Georgia and South Carolina (Baker-Austin et al., 2008), in E. coli O157:H7 from retail shrimp from India 
(Surendraraj et al., 2010), in V. parahaemolyticus and V. alginolyticus from farmed fish from Korea (Oh et 
al.,2011) , and in Salmonella from imported seafood (Khan et al.,2009). 
The observation that similar or even identical gene cassettes have been detected in bacteria from fish, 
humans, food-producing animals and/or companion animals suggests that there is an inter-connection among 
these microbial ecosystems, with the sharing of a common AR gene pool, thereby influencing the evolution of 
ART bacteria (Kadlec et al., 2011). 
 
Ready-to-consume and restaurant foods 
Compared to raw foods, ready-to-consume products – including processed dairy, meat, seafood and vegetable 
products and restaurant foods – are usually ingested directly without further processing. Therefore, the number 
of ART microorganisms in these products gives an indication of the actual risk of oral exposure to ART 
microbes through food intake (López et al., 2008). Listeria monocytogenes were present in 3% of more than 
three thousand ready-to-consume foods (sandwiches, smoked turkey, beef, and ham) sampled in Florida and 
78% of these isolates exhibited multidrug-resistance to ciprofloxacin, tetracycline and others. The microbiota of 
ready-to-consume foods are affected by the microorganisms associated with raw materials, as well as by post-
harvesting processing, handling and storage procedures before consumption (Shen et al., 2011). 
 
COMMON ANTIBIOTIC RESIDUES IN FOOD 
Data from studies of antibiotic-resistant bacteria isolated from meat (reported in papers published 2000–2005) 
were examined. From a consideration of all these sources, the following drugs were considered as the most likely 
to be detected in meat: Penicillin (including ampicillin), Tetracycline (including chlortetracycline and 
oxytetracycline), Sulfonamides (including sulfadimethoxine, sulfamethazine and sulfamethoxazole), Neomycin, 
Gentamicin, Flunixin, Streptomycin, Arsenicals. The hypothesis was that the greater the amount of a drug used, 
the more likely bacteria would develop resistance to it (Boothe and Arnold, 2003). 
Results from the 2003 FSIS National Residue Monitoring Plan indicate that penicillin and sulfonamide 
drugs were most commonly detected at violative levels in swine and cattle. Neomycin and gentamicin were also 
detected in a number of cattle, particularly calves. Other drugs detected in cattle and swine included tilmicosin, 
flunixin, and tetracyclines. Arsenicals were detected in poultry. Data from 1996 indicated the percentage of 
violative residues accounted for by each drug: CAST (calf antibiotic sulfa test), 32%; penicillin, 20%; 
oxytetracycline, 10%; sulfamethazine plus sulfadimethoxine, 10%; tetracycline, 8%; gentamicin, 6%; neomycin, 
3%; other, 7% (Paige et al., 1999). 
Warning letters sent by FDA in USA in to cattle producers in with animals containing violative residues 
were tallied for 2003–2005. Penicillin, sulfonamides, Gentamicin, flunixin, and neomycin were most often 
detected in violation. Other drugs detected were tetracyclines and tilmicosin (FSIS, 2006). 
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Table 1: Drug residues among cattle slaughtered from 2003–2005 in USA according to FDA 
 
Drugs 
# animals cited Range of concentrations [ppm] 
‘05 ‘04 ‘03 Kidney Liver Muscle 
Dihydrostreptomycin 3   4.19–6.37   
Flunixin 4 17 14  0.125–14.12  
Gentamicin 4 14 13 0.19–106.54 0.297–5.0 0.32 
Neomycin 11 22 4 0.02–443.39 15.27 detectable 
Oxytetracycline/tetracycline 1 7 8 14.83–154.7 6.1–48.17 2.86–42.88 
Penicillin 24 37 55 0.06–18.68 0.06–0.80 0.12–0.83 
Sulfadimethoxine / sulfamethazine 17 22 49 4.93–6.1 0.10–52.33 0.1–54.91 
Tilmicosin 4 2 11 2.2–28.17 1.44–38.96 0.94–13.19 
Residues of all veterinary drugs are higher in liver and/or kidney tissue as compared to muscle tissue. Analyses 
have shown that residue levels of some antibiotics can be different in different poultry muscle tissues (Reyes et 
al., 2005).  
 
IMPACT OF THE USE OF ANTIBIOTICS IN LIVESTOCK PRODUCTION 
Indiscriminate use of antibiotics may lead to antibiotic residues and antibiotic resistance. Antibiotics and 
antibiotic-resistant bacteria can be found in the air, groundwater, and soil around farms and on retail meat (Smith 
et al.,2005) and people can be exposed to these pathogens through infected meat, vegetables fertilized with raw 
manure, and water supplies contaminated by farm animal waste (Acar and Moulin, 2006). When resistant 
bacteria are themselves pathogenic or can transfer their resistance genes to pathogenic bacteria, adverse health 
effects can result (WHO, 1997). 
Until very recently, controls on antibiotic use in animals focused almost exclusively on the control of 
residues in the tissues of treated animals. Concerns about residues revolve around allergic reactions and the 
possible adverse effects on the flora of the human gastrointestinal tract (selecting for resistance or transfer of 
resistance). For example penicillin residues in milk could provoke allergic reactions in sensitised individuals, but 
there were no other adverse effects associated with antibiotic residues (Swann, 2009). 
Confirmed cases of allergy to substances in food are very rare, although adverse reactions to antibiotics 
have been linked to hypersensitivity and cases of chronic urticaria (Woodward, 1991). A rare fatal blood 
dyscrasia in individuals sensitised to chloramphenicol could also be triggered by chloramphenicol residues in 
food (Settepani, 2004). 
 
THE WAYS FORWARDED TO CONTROL ANTIBIOTICS RESISTANCE 
Responsible Use 
Guidelines exist for responsible (proper, appropriate, prudent, or judicious) use of antibiotics in veterinary and 
human medicine, and are similar in the medical and agricultural sectors (Phillips et al., 2004). Veterinary and 
animal producer organizations in many countries have developed and implemented responsible use principles or 
guidelines. These address use in various species, including poultry, swine, dairy and beef cattle, and sheep. 
International organizations, such as the OIE, WHO, also have developed or are developing principles or codes of 
practice to contain antibiotic resistance. The WHO published Global Principles for the Containment of 
Antimicrobial Resistance in Animals Intended for Food (WHO, 2000). 
The OIE issued 5 documents concerning antibiotic resistance, including Guidelines for the Responsible 
and Prudent Use of Antimicrobial Agents in Veterinary Medicine. The other 4 documents deal with risk analysis 
methodology, monitoring of use quantities, surveillance programs, and laboratory methodologies (Acar and 
Rostel, 2001). 
Most of the recommendations of the various guidelines can be summarized in three objectives: 
1. emphasize actions to prevent disease, thereby eliminating the need for therapeutic use of antibiotics; 
2. if a disease occurs in or threatens animals, consider methods other than antibiotic use to mitigate or 
prevent the effects of the disease; and 
3. If antibiotics are necessary to prevent, control or treat a disease, first consider the use of antibiotics that 
are less important to human or veterinary medicine (WHO, 2000). 
 
Alternative Practices 
Herd, flock, and other health management programs overseen by veterinary or other professionals attempt to 
minimize infectious disease outbreaks by using non-antibiotic interventions early in the life of the animals. The 
rationale is to promote healthy animals that do not become ill and are, thus, unlikely to be treated with an 
antibiotic agent. Several current approaches are available. These non-antibiotic approaches have led to a need to 
establish performance standards for regulatory and commercial purposes (Rosen, 2003). 
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Preventing infectious diseases in animals 
Antibiotics are probably the most valuable drugs in animal production, and maintaining their beneficial effect is 
therefore of utmost importance. Focus should be given to the continuous implementation of appropriate 
measures for disease prevention, to decrease the need for antibiotics. To minimize infection in food-animal 
production and decrease the volume of antibiotics used, efforts should aim to improve animal health, thereby 
eliminating or reducing the need for antibiotics for treatment or prophylaxis. This can be achieved by improving 
hygiene, biosecurity and health management on farms and preventing disease through the use of vaccines and 
other measures such as probiotics (beneficial bacteria found in various foods), prebiotics (non-digestible foods 
that help probiotic bacteria grow and flourish) or competitive exclusion products (intestinal bacterial flora that 
limit the colonization of some bacterial pathogens) (WHO, 2011). 
 
Vaccines 
Vaccines have been a key component of disease prevention for many years because they have many favourable 
attributes such as low cost, ease of administration, efficacy, multiple agent efficacy (viruses, bacteria, 
mycoplasma, and parasites, for example), and safety (worker, animal, environmental, lack of food residue). 
Adjuvants are sometimes included with vaccines to enhance the immune response. Various delivery systems or 
routes of administration (for example muscle injection or, aerosol, topical, or oral [mucosal]) are used to 
administer the vaccine into the animal (Klesius et al., 2000). 
Future research in veterinary vaccine adjuvants will focus on particle delivery to antigen presenting 
cells and immunostimulatory adjuvants to affect a higher and longer lasting state of immune response 
(Lowenthal et al., 2000). New oral delivery systems, such as plant-based vaccines, are being developed that offer 
ease of administration, production, and other benefits, although the regulatory acceptance of these products 
remains to be clarified (Streatfield and Howard, 2003). 
 
Competitive exclusion 
Direct-fed microbial products containing live microorganisms (known as probiotics) or products containing 
enzymes as the active ingredient are currently marketed in many countries. Probiotics, which contain one or 
more types of microorganisms and are administered orally, are currently approved for use in food animals in 
Europe and other countries, but as for the use of antibiotics for growth promotion, their mode of action is not 
fully understood. Probiotic bacteria could affect normal gut microflora by competitive exclusion of pathogenic 
bacteria, production of antibacterial products or enzymes that act on gut bacteria, or production of other 
metabolites that affect gut commensals (Anonymous, 2006b). 
Other approaches are the use of prebiotics (nondigestible oligosaccharides) that permit beneficial gut 
bacteria to preferentially thrive, thus promoting overall host health (Mosenthin and Bauer, 2000). 
Supplementation of feedstuffs with phytase, an enzyme that allows greater host utilization of phosphorous, has 
also been advocated (Hatten et al., 2001). 
 
Antimicrobial peptides 
Antimicrobial peptides are host-cell-produced compounds that have been identified in plants, animals, and 
insects. Extensive research has led to an increased understanding of the mechanisms of action of porcine 
antimicrobial peptides, but has not addressed the numerous practical aspects that are necessary to achieve 
regulatory approval or marketplace success (Zhang et al., 2000). 
 
Bacteriocins  
Pore-forming antibacterial proteins produced by microorganisms, bacteriocins have been investigated for their 
potential use in the control of certain zoonotic pathogens in the avian intestinal tract. One bacteriocin, nisin, has 
been approved for use in several food products (Cleveland et al., 2001). 
 
Bacteriophages 
Bacteriophages have been used successfully to prevent and treat bacterial diseases in humans and animals in 
Russia, but have failed to gain acceptance in Western countries owing to the focus on antibiotic use (Barrow, 
2001). 
The possibility of using avian cytokines as potential therapeutic agents has also been reported, but 
issues including dose and safety have not been resolved (Lowenthal et al., 2000). As anti-infectives, 
bacteriophages have several attractive attributes including specificity, since each bacteriophage is directed 
toward a single kind of bacterium (although this results in a limited host range), lethality, projected low cost, and 
no residues in the food product. However, questions surrounding the safety of using recombinant therapies, 
environmental containment, and phage resistance remain unresolved (Moldave and Rhodes, 2003). 
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Alternative management practices  
The management measures will be implemented by applying one or more management practices appropriate to 
the site, location, type of operation, and climate which are favourable for animal keeping. Several industries have 
found benefit in modifying practices as an alternative to antibiotic use (Lowenthal et al.,2000). 
 
ANTIBIOTIC RESISTANCE AND RESIDUE IN ETHIOPIA 
Emergence of antibiotics resistance is a result of the use, overuse and misuse of antibiotics both in humans and 
animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled 
practitioners, and drug consumers. These coupled with rapid spread of resistant bacteria and inadequate 
surveillance contributed to the problem. Studies on antibacterial resistance and on bacterial infections have 
shown that emerging antibacterial resistance threatens the management of bacterial infections; however, the 
prevention and containment has received far too little attention. The consequences of these states of affairs 
include increased mortality, morbidity, costs of treatment, and loss of production in animals (DACAE and 
MSH/SPS, 2009). 
In Ethiopia the control of drugs from the government authorities and information on the actual rational 
drug use pertaining to veterinary drug use is very limited. In addition, misuses of drugs are common among the 
various sectors including veterinary and public health. In addition there is lack of awareness and preparedness 
among the controlling authorities and producers in dealing with the risk of indiscriminate use of antibiotics to the 
livestock and to the consumers. Food animals slaughtered for domestic and export purposes in the country are 
not screened for the presence of residues in any of the slaughterhouses in the country. No formal control 
mechanisms exist to protect the consumers against the consumption of meat and milk products containing 
harmful drug residues in the country (Addisalem and Bayleyegn, 2012). 
A cross-sectional study was conducted from October 2006 to May 2007 to estimate the proportion of 
tetracyclines (oxytetracycline, tetracycline and doxycycline) levels in beef; the study focused on the Addis 
Ababa, Debre Zeit, and Nazareth slaughterhouses. Out of the total 384 samples analyzed for tetracycline 
residues, 71.3% had detectable oxytetracycline levels. Among the meat samples collected from the Addis Ababa, 
Debre Zeit, and Nazareth slaughterhouses, 93.8%, 37.5%, and 82.1% tested positive for oxytetracycline. The 
mean levels of oxytetracycline in muscle from the three slaughterhouses were as follows: Addis Ababa, 108.34 
µg/kg; Nazareth, 64.85 µg/kg; and Debre Zeit, 15.916 µg/kg. Regarding kidney samples, oxytetracycline levels 
were found to be 99.02 µg/ kg in Addis Ababa, 109.35 µg/kg in Nazareth, and 112.53 µg/kg in Debre Zeit. 
About 48% of the edible tissues had oxytetracycline levels above the recommended maximum limits 
(Myllyniemi et al., 2000). 
 
CONCULISION AND RECOMMENDATION 
Antibiotic resistance related to food safety is an increasing public health problem. Modern food-animal 
production uses large amounts of antibiotics not only for therapeutic purposes but also to prevent disease and 
promote animal growth. As a result, large numbers of healthy animals are routinely or often exposed to 
antibiotics. This provides favourable conditions for the emergence, development, spread and persistence of 
antibiotic-resistant bacteria capable of causing infections in animals and people. Resistant zoonotic bacteria 
carried by food animals can spread to and infect people, usually through food but also through direct contact 
with animals or environmental spread. The genes that encode antibiotic resistance can also be transferred from 
commensal bacteria to human pathogens. Because food animals and foods of animal origin are traded 
worldwide, antibiotic resistance affecting the food supply of one country becomes a potential problem for others. 
Thus based on the above conclusions the following recommendations are forwarded: 
♦ Antibiotics use in food animals should be reduced by improving animal health through bio security 
measures.  
♦ Antibiotics should be administered to food animals only professionals. 
♦ Narrow-spectrum antibiotics should be the first choice when antibiotic therapy is justified. 
♦ Use of antibiotics as growth promoters should be prohibited. 
♦ Antibiotics should be used only therapeutically and they should be given to sick animals based on the 
results of resistance surveillance 
♦ Study should be conducted in Ethiopia to determine the level of antibiotic resistant pathogens in 
different food items.  
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